Clinical Trial Update: Genomic Effects of Glucocorticoids in Patients With Systemic Lupus Erythematosus [EARLY_Phase 1]

View source ↗

Summary

This early-phase 1 study investigates the genomic effects of glucocorticoids in patients with systemic lupus erythematosus. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Glucocorticoids (class) (glucocorticoids)

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Systemic Lupus Erythematous (SLE) | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2023-08-21